Precision Optics Corporation, Inc.
Precision Optics Corporation, Inc. POCI Peers
See (POCI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| POCI | $4.52 | -5.24% | 34.65M | -6.95 | -$0.65 | N/A |
| ISRG | $563.60 | +0.59% | 202.00B | 82.40 | $6.84 | N/A |
| BDX | $175.40 | +1.82% | 50.27B | 33.93 | $5.17 | +2.27% |
| BDXA | $59.24 | -2.24% | 47.95B | 21.44 | $2.76 | +2.27% |
| ALC | $89.82 | +2.45% | 44.42B | 39.74 | $2.26 | +0.37% |
| RMD | $251.62 | +1.22% | 36.89B | 28.27 | $8.90 | +0.85% |
| COO | $82.92 | +1.80% | 16.58B | 40.06 | $2.07 | N/A |
| BAX | $31.67 | +2.03% | 16.25B | -60.90 | -$0.52 | +2.91% |
| WST | $216.54 | +2.78% | 15.56B | 33.99 | $6.37 | +0.39% |
| BDXB | $48.16 | +1.39% | 13.69B | 7.60 | $6.33 | +2.27% |
Stock Comparison
POCI vs ISRG Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ISRG has a market cap of 202.00B. Regarding current trading prices, POCI is priced at $4.52, while ISRG trades at $563.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ISRG's P/E ratio is 82.40. In terms of profitability, POCI's ROE is -0.54%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, POCI is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs BDX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, BDX has a market cap of 50.27B. Regarding current trading prices, POCI is priced at $4.52, while BDX trades at $175.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas BDX's P/E ratio is 33.93. In terms of profitability, POCI's ROE is -0.54%, compared to BDX's ROE of +0.06%. Regarding short-term risk, POCI is less volatile compared to BDX. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs BDXA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, BDXA has a market cap of 47.95B. Regarding current trading prices, POCI is priced at $4.52, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas BDXA's P/E ratio is 21.44. In terms of profitability, POCI's ROE is -0.54%, compared to BDXA's ROE of +0.06%. Regarding short-term risk, POCI is less volatile compared to BDXA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ALC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ALC has a market cap of 44.42B. Regarding current trading prices, POCI is priced at $4.52, while ALC trades at $89.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ALC's P/E ratio is 39.74. In terms of profitability, POCI's ROE is -0.54%, compared to ALC's ROE of +0.07%. Regarding short-term risk, POCI is more volatile compared to ALC. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs RMD Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, RMD has a market cap of 36.89B. Regarding current trading prices, POCI is priced at $4.52, while RMD trades at $251.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas RMD's P/E ratio is 28.27. In terms of profitability, POCI's ROE is -0.54%, compared to RMD's ROE of +0.25%. Regarding short-term risk, POCI is more volatile compared to RMD. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs COO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, COO has a market cap of 16.58B. Regarding current trading prices, POCI is priced at $4.52, while COO trades at $82.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas COO's P/E ratio is 40.06. In terms of profitability, POCI's ROE is -0.54%, compared to COO's ROE of +0.05%. Regarding short-term risk, POCI is less volatile compared to COO. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs BAX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, BAX has a market cap of 16.25B. Regarding current trading prices, POCI is priced at $4.52, while BAX trades at $31.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas BAX's P/E ratio is -60.90. In terms of profitability, POCI's ROE is -0.54%, compared to BAX's ROE of -0.07%. Regarding short-term risk, POCI is less volatile compared to BAX. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs WST Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, WST has a market cap of 15.56B. Regarding current trading prices, POCI is priced at $4.52, while WST trades at $216.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas WST's P/E ratio is 33.99. In terms of profitability, POCI's ROE is -0.54%, compared to WST's ROE of +0.17%. Regarding short-term risk, POCI is less volatile compared to WST. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs BDXB Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, BDXB has a market cap of 13.69B. Regarding current trading prices, POCI is priced at $4.52, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas BDXB's P/E ratio is 7.60. In terms of profitability, POCI's ROE is -0.54%, compared to BDXB's ROE of +0.06%. Regarding short-term risk, POCI is less volatile compared to BDXB. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs HOLX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, HOLX has a market cap of 12.66B. Regarding current trading prices, POCI is priced at $4.52, while HOLX trades at $56.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas HOLX's P/E ratio is 23.86. In terms of profitability, POCI's ROE is -0.54%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, POCI is less volatile compared to HOLX. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ATR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ATR has a market cap of 10.37B. Regarding current trading prices, POCI is priced at $4.52, while ATR trades at $157.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ATR's P/E ratio is 28.71. In terms of profitability, POCI's ROE is -0.54%, compared to ATR's ROE of +0.15%. Regarding short-term risk, POCI is more volatile compared to ATR. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs MASI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, MASI has a market cap of 8.44B. Regarding current trading prices, POCI is priced at $4.52, while MASI trades at $155.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas MASI's P/E ratio is -28.45. In terms of profitability, POCI's ROE is -0.54%, compared to MASI's ROE of -0.41%. Regarding short-term risk, POCI is more volatile compared to MASI. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs RGEN Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, RGEN has a market cap of 7.11B. Regarding current trading prices, POCI is priced at $4.52, while RGEN trades at $126.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas RGEN's P/E ratio is -275.00. In terms of profitability, POCI's ROE is -0.54%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, POCI is less volatile compared to RGEN. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs STVN Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, STVN has a market cap of 6.54B. Regarding current trading prices, POCI is priced at $4.52, while STVN trades at $23.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas STVN's P/E ratio is 46.12. In terms of profitability, POCI's ROE is -0.54%, compared to STVN's ROE of +0.09%. Regarding short-term risk, POCI is less volatile compared to STVN. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs MMSI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, MMSI has a market cap of 5.84B. Regarding current trading prices, POCI is priced at $4.52, while MMSI trades at $98.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas MMSI's P/E ratio is 48.45. In terms of profitability, POCI's ROE is -0.54%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, POCI is more volatile compared to MMSI. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs TFX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, TFX has a market cap of 5.71B. Regarding current trading prices, POCI is priced at $4.52, while TFX trades at $129.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas TFX's P/E ratio is 40.03. In terms of profitability, POCI's ROE is -0.54%, compared to TFX's ROE of +0.03%. Regarding short-term risk, POCI is less volatile compared to TFX. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs BLCO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, BLCO has a market cap of 4.16B. Regarding current trading prices, POCI is priced at $4.52, while BLCO trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas BLCO's P/E ratio is -11.53. In terms of profitability, POCI's ROE is -0.54%, compared to BLCO's ROE of -0.08%. Regarding short-term risk, POCI is more volatile compared to BLCO. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs HAE Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, HAE has a market cap of 3.53B. Regarding current trading prices, POCI is priced at $4.52, while HAE trades at $70.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas HAE's P/E ratio is 21.25. In terms of profitability, POCI's ROE is -0.54%, compared to HAE's ROE of +0.18%. Regarding short-term risk, POCI is more volatile compared to HAE. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs ICUI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ICUI has a market cap of 3.48B. Regarding current trading prices, POCI is priced at $4.52, while ICUI trades at $141.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ICUI's P/E ratio is -36.82. In terms of profitability, POCI's ROE is -0.54%, compared to ICUI's ROE of -0.05%. Regarding short-term risk, POCI is more volatile compared to ICUI. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs XRAY Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, XRAY has a market cap of 3.33B. Regarding current trading prices, POCI is priced at $4.52, while XRAY trades at $16.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas XRAY's P/E ratio is -3.74. In terms of profitability, POCI's ROE is -0.54%, compared to XRAY's ROE of -0.38%. Regarding short-term risk, POCI is more volatile compared to XRAY. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs QDEL Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, QDEL has a market cap of 2.26B. Regarding current trading prices, POCI is priced at $4.52, while QDEL trades at $33.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas QDEL's P/E ratio is -6.40. In terms of profitability, POCI's ROE is -0.54%, compared to QDEL's ROE of -0.11%. Regarding short-term risk, POCI is less volatile compared to QDEL. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs WRBY Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, WRBY has a market cap of 2.15B. Regarding current trading prices, POCI is priced at $4.52, while WRBY trades at $17.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas WRBY's P/E ratio is -147.67. In terms of profitability, POCI's ROE is -0.54%, compared to WRBY's ROE of -0.04%. Regarding short-term risk, POCI is more volatile compared to WRBY. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs NVCR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, NVCR has a market cap of 1.99B. Regarding current trading prices, POCI is priced at $4.52, while NVCR trades at $17.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas NVCR's P/E ratio is -11.85. In terms of profitability, POCI's ROE is -0.54%, compared to NVCR's ROE of -0.45%. Regarding short-term risk, POCI is less volatile compared to NVCR. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs LMAT Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, LMAT has a market cap of 1.92B. Regarding current trading prices, POCI is priced at $4.52, while LMAT trades at $84.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas LMAT's P/E ratio is 43.03. In terms of profitability, POCI's ROE is -0.54%, compared to LMAT's ROE of +0.14%. Regarding short-term risk, POCI is less volatile compared to LMAT. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ATRC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ATRC has a market cap of 1.62B. Regarding current trading prices, POCI is priced at $4.52, while ATRC trades at $32.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ATRC's P/E ratio is -40.38. In terms of profitability, POCI's ROE is -0.54%, compared to ATRC's ROE of -0.08%. Regarding short-term risk, POCI is less volatile compared to ATRC. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs KMTS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, KMTS has a market cap of 1.26B. Regarding current trading prices, POCI is priced at $4.52, while KMTS trades at $24.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas KMTS's P/E ratio is -12.82. In terms of profitability, POCI's ROE is -0.54%, compared to KMTS's ROE of N/A. Regarding short-term risk, POCI is less volatile compared to KMTS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs AZTA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, AZTA has a market cap of 1.26B. Regarding current trading prices, POCI is priced at $4.52, while AZTA trades at $27.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas AZTA's P/E ratio is -8.40. In terms of profitability, POCI's ROE is -0.54%, compared to AZTA's ROE of -0.04%. Regarding short-term risk, POCI is less volatile compared to AZTA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs PLSE Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, PLSE has a market cap of 1.16B. Regarding current trading prices, POCI is priced at $4.52, while PLSE trades at $17.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas PLSE's P/E ratio is -17.36. In terms of profitability, POCI's ROE is -0.54%, compared to PLSE's ROE of -0.71%. Regarding short-term risk, POCI is less volatile compared to PLSE. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs BLFS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, BLFS has a market cap of 1.12B. Regarding current trading prices, POCI is priced at $4.52, while BLFS trades at $23.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas BLFS's P/E ratio is -124.16. In terms of profitability, POCI's ROE is -0.54%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, POCI is less volatile compared to BLFS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs STAA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, STAA has a market cap of 951.89M. Regarding current trading prices, POCI is priced at $4.52, while STAA trades at $19.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas STAA's P/E ratio is -13.35. In terms of profitability, POCI's ROE is -0.54%, compared to STAA's ROE of -0.18%. Regarding short-term risk, POCI is less volatile compared to STAA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ATRI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ATRI has a market cap of 809.44M. Regarding current trading prices, POCI is priced at $4.52, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ATRI's P/E ratio is 64.50. In terms of profitability, POCI's ROE is -0.54%, compared to ATRI's ROE of +0.05%. Regarding short-term risk, POCI is more volatile compared to ATRI. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs ANGO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ANGO has a market cap of 381.71M. Regarding current trading prices, POCI is priced at $4.52, while ANGO trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ANGO's P/E ratio is -9.31. In terms of profitability, POCI's ROE is -0.54%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, POCI is less volatile compared to ANGO. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NNNN Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, NNNN has a market cap of 330.94M. Regarding current trading prices, POCI is priced at $4.52, while NNNN trades at $7.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas NNNN's P/E ratio is 150.80. In terms of profitability, POCI's ROE is -0.54%, compared to NNNN's ROE of N/A. Regarding short-term risk, POCI is less volatile compared to NNNN. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs SMTI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, SMTI has a market cap of 278.19M. Regarding current trading prices, POCI is priced at $4.52, while SMTI trades at $31.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas SMTI's P/E ratio is -27.46. In terms of profitability, POCI's ROE is -0.54%, compared to SMTI's ROE of -0.29%. Regarding short-term risk, POCI is less volatile compared to SMTI. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NYXH Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, NYXH has a market cap of 216.29M. Regarding current trading prices, POCI is priced at $4.52, while NYXH trades at $6.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas NYXH's P/E ratio is -3.11. In terms of profitability, POCI's ROE is -0.54%, compared to NYXH's ROE of -0.56%. Regarding short-term risk, POCI is less volatile compared to NYXH. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs OSUR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, OSUR has a market cap of 181.76M. Regarding current trading prices, POCI is priced at $4.52, while OSUR trades at $2.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas OSUR's P/E ratio is -5.79. In terms of profitability, POCI's ROE is -0.54%, compared to OSUR's ROE of -0.08%. Regarding short-term risk, POCI is less volatile compared to OSUR. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs UTMD Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, UTMD has a market cap of 180.83M. Regarding current trading prices, POCI is priced at $4.52, while UTMD trades at $55.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas UTMD's P/E ratio is 14.54. In terms of profitability, POCI's ROE is -0.54%, compared to UTMD's ROE of +0.11%. Regarding short-term risk, POCI is less volatile compared to UTMD. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs STXS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, STXS has a market cap of 178.45M. Regarding current trading prices, POCI is priced at $4.52, while STXS trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas STXS's P/E ratio is -6.69. In terms of profitability, POCI's ROE is -0.54%, compared to STXS's ROE of -2.17%. Regarding short-term risk, POCI is less volatile compared to STXS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ZTEK Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ZTEK has a market cap of 165.85M. Regarding current trading prices, POCI is priced at $4.52, while ZTEK trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ZTEK's P/E ratio is -19.87. In terms of profitability, POCI's ROE is -0.54%, compared to ZTEK's ROE of -0.58%. Regarding short-term risk, POCI is less volatile compared to ZTEK. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs PDEX Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, PDEX has a market cap of 140.62M. Regarding current trading prices, POCI is priced at $4.52, while PDEX trades at $43.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas PDEX's P/E ratio is 15.62. In terms of profitability, POCI's ROE is -0.54%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, POCI is less volatile compared to PDEX. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs KRMD Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, KRMD has a market cap of 136.12M. Regarding current trading prices, POCI is priced at $4.52, while KRMD trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas KRMD's P/E ratio is -24.58. In terms of profitability, POCI's ROE is -0.54%, compared to KRMD's ROE of -0.30%. Regarding short-term risk, POCI is less volatile compared to KRMD. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs INFU Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, INFU has a market cap of 129.10M. Regarding current trading prices, POCI is priced at $4.52, while INFU trades at $6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas INFU's P/E ratio is 41.03. In terms of profitability, POCI's ROE is -0.54%, compared to INFU's ROE of +0.08%. Regarding short-term risk, POCI is less volatile compared to INFU. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs ZJYL Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, ZJYL has a market cap of 124.78M. Regarding current trading prices, POCI is priced at $4.52, while ZJYL trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas ZJYL's P/E ratio is 39.86. In terms of profitability, POCI's ROE is -0.54%, compared to ZJYL's ROE of +0.13%. Regarding short-term risk, POCI is less volatile compared to ZJYL. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs MBOT Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, MBOT has a market cap of 97.49M. Regarding current trading prices, POCI is priced at $4.52, while MBOT trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas MBOT's P/E ratio is -3.67. In terms of profitability, POCI's ROE is -0.54%, compared to MBOT's ROE of -0.85%. Regarding short-term risk, POCI is less volatile compared to MBOT. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs MLSS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, MLSS has a market cap of 71.17M. Regarding current trading prices, POCI is priced at $4.52, while MLSS trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas MLSS's P/E ratio is -15.13. In terms of profitability, POCI's ROE is -0.54%, compared to MLSS's ROE of -0.83%. Regarding short-term risk, POCI is less volatile compared to MLSS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs AKYA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, AKYA has a market cap of 51.37M. Regarding current trading prices, POCI is priced at $4.52, while AKYA trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas AKYA's P/E ratio is -0.87. In terms of profitability, POCI's ROE is -0.54%, compared to AKYA's ROE of -5.06%. Regarding short-term risk, POCI is less volatile compared to AKYA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs OMIC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, OMIC has a market cap of 50.77M. Regarding current trading prices, POCI is priced at $4.52, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas OMIC's P/E ratio is -0.58. In terms of profitability, POCI's ROE is -0.54%, compared to OMIC's ROE of -0.58%. Regarding short-term risk, POCI is more volatile compared to OMIC. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs IGAP Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, IGAP has a market cap of 50.23M. Regarding current trading prices, POCI is priced at $4.52, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas IGAP's P/E ratio is -10.52. In terms of profitability, POCI's ROE is -0.54%, compared to IGAP's ROE of +3.93%. Regarding short-term risk, POCI is more volatile compared to IGAP. This indicates potentially higher risk in terms of short-term price fluctuations for POCI.
POCI vs DXR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, DXR has a market cap of 36.13M. Regarding current trading prices, POCI is priced at $4.52, while DXR trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas DXR's P/E ratio is -83.00. In terms of profitability, POCI's ROE is -0.54%, compared to DXR's ROE of +0.02%. Regarding short-term risk, POCI is less volatile compared to DXR. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs SDC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, SDC has a market cap of 29.11M. Regarding current trading prices, POCI is priced at $4.52, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas SDC's P/E ratio is -0.03. In terms of profitability, POCI's ROE is -0.54%, compared to SDC's ROE of -1.96%. Regarding short-term risk, POCI is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs FEMY Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, FEMY has a market cap of 28.87M. Regarding current trading prices, POCI is priced at $4.52, while FEMY trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas FEMY's P/E ratio is -1.16. In terms of profitability, POCI's ROE is -0.54%, compared to FEMY's ROE of -3.92%. Regarding short-term risk, POCI is less volatile compared to FEMY. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs IVC Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, IVC has a market cap of 24.91M. Regarding current trading prices, POCI is priced at $4.52, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas IVC's P/E ratio is -0.79. In terms of profitability, POCI's ROE is -0.54%, compared to IVC's ROE of -0.46%. Regarding short-term risk, POCI is less volatile compared to IVC. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NEPH Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, NEPH has a market cap of 22.90M. Regarding current trading prices, POCI is priced at $4.52, while NEPH trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas NEPH's P/E ratio is 27.00. In terms of profitability, POCI's ROE is -0.54%, compared to NEPH's ROE of +0.09%. Regarding short-term risk, POCI is less volatile compared to NEPH. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs RVP Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, RVP has a market cap of 22.45M. Regarding current trading prices, POCI is priced at $4.52, while RVP trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas RVP's P/E ratio is -1.87. In terms of profitability, POCI's ROE is -0.54%, compared to RVP's ROE of -0.27%. Regarding short-term risk, POCI is less volatile compared to RVP. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NXGL Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, NXGL has a market cap of 18.45M. Regarding current trading prices, POCI is priced at $4.52, while NXGL trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas NXGL's P/E ratio is -4.82. In terms of profitability, POCI's ROE is -0.54%, compared to NXGL's ROE of -0.63%. Regarding short-term risk, POCI is less volatile compared to NXGL. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NXGLW Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, NXGLW has a market cap of 16.55M. Regarding current trading prices, POCI is priced at $4.52, while NXGLW trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas NXGLW's P/E ratio is -0.22. In terms of profitability, POCI's ROE is -0.54%, compared to NXGLW's ROE of -0.63%. Regarding short-term risk, POCI is less volatile compared to NXGLW. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs HBIO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, HBIO has a market cap of 15.01M. Regarding current trading prices, POCI is priced at $4.52, while HBIO trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas HBIO's P/E ratio is -0.26. In terms of profitability, POCI's ROE is -0.54%, compared to HBIO's ROE of -1.10%. Regarding short-term risk, POCI is less volatile compared to HBIO. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs LUCYW Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, LUCYW has a market cap of 13.82M. Regarding current trading prices, POCI is priced at $4.52, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas LUCYW's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to LUCYW's ROE of -0.95%. Regarding short-term risk, POCI is less volatile compared to LUCYW. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs MHUA Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, MHUA has a market cap of 12.52M. Regarding current trading prices, POCI is priced at $4.52, while MHUA trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas MHUA's P/E ratio is 0.99. In terms of profitability, POCI's ROE is -0.54%, compared to MHUA's ROE of +0.09%. Regarding short-term risk, POCI is less volatile compared to MHUA. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs EKSO Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, EKSO has a market cap of 10.87M. Regarding current trading prices, POCI is priced at $4.52, while EKSO trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas EKSO's P/E ratio is -0.78. In terms of profitability, POCI's ROE is -0.54%, compared to EKSO's ROE of -0.82%. Regarding short-term risk, POCI is less volatile compared to EKSO. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs POAI Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, POAI has a market cap of 9.65M. Regarding current trading prices, POCI is priced at $4.52, while POAI trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas POAI's P/E ratio is -0.54. In terms of profitability, POCI's ROE is -0.54%, compared to POAI's ROE of -5.91%. Regarding short-term risk, POCI is less volatile compared to POAI. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs LUCY Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, LUCY has a market cap of 8.67M. Regarding current trading prices, POCI is priced at $4.52, while LUCY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas LUCY's P/E ratio is -0.54. In terms of profitability, POCI's ROE is -0.54%, compared to LUCY's ROE of -0.95%. Regarding short-term risk, POCI is less volatile compared to LUCY. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs WOK Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, WOK has a market cap of 7.57M. Regarding current trading prices, POCI is priced at $4.52, while WOK trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas WOK's P/E ratio is -1.92. In terms of profitability, POCI's ROE is -0.54%, compared to WOK's ROE of N/A. Regarding short-term risk, POCI is less volatile compared to WOK. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs NSTG Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, NSTG has a market cap of 5.07M. Regarding current trading prices, POCI is priced at $4.52, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas NSTG's P/E ratio is -0.03. In terms of profitability, POCI's ROE is -0.54%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, POCI is less volatile compared to NSTG. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs STSS Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, STSS has a market cap of 4.66M. Regarding current trading prices, POCI is priced at $4.52, while STSS trades at $4.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas STSS's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to STSS's ROE of -0.99%. Regarding short-term risk, POCI is less volatile compared to STSS. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs GCTK Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, GCTK has a market cap of 4.30M. Regarding current trading prices, POCI is priced at $4.52, while GCTK trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas GCTK's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to GCTK's ROE of +3.93%. Regarding short-term risk, POCI is less volatile compared to GCTK. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs GMVD Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, GMVD has a market cap of 1.80M. Regarding current trading prices, POCI is priced at $4.52, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas GMVD's P/E ratio is -0.01. In terms of profitability, POCI's ROE is -0.54%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, POCI is less volatile compared to GMVD. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs GMVDW Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, GMVDW has a market cap of 1.80M. Regarding current trading prices, POCI is priced at $4.52, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas GMVDW's P/E ratio is N/A. In terms of profitability, POCI's ROE is -0.54%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, POCI is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.
POCI vs AVGR Comparison
POCI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POCI stands at 34.65M. In comparison, AVGR has a market cap of 1.52M. Regarding current trading prices, POCI is priced at $4.52, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POCI currently has a P/E ratio of -6.95, whereas AVGR's P/E ratio is -0.05. In terms of profitability, POCI's ROE is -0.54%, compared to AVGR's ROE of -54.25%. Regarding short-term risk, POCI is less volatile compared to AVGR. This indicates potentially lower risk in terms of short-term price fluctuations for POCI.